![]() |
市場調查報告書
商品編碼
1722552
2025 年至 2033 年皮下注射針市場報告(按產品類型、應用、最終用戶和地區)Hypodermic Needles Market Report by Product Type, Application, End User, and Region 2025-2033 |
2024 年全球皮下注射針市場規模達 31 億美元。展望未來, IMARC Group預計到 2033 年市場規模將達到 53 億美元,2025-2033 年期間的成長率 (CAGR) 為 5.91%。由於慢性病發病率不斷上升、疫苗和注射藥物需求不斷成長、針頭技術突破提高了患者的舒適度和安全性,以及世界各地特別是新興經濟體戰略醫療保健基礎設施的擴張,市場正在經歷顯著成長。
主要市場促進因素:注射針市場的成長主要受到需要注射藥物的慢性病盛行率上升、疫苗和治療藥物需求增加、技術進步提高針頭安全性和患者舒適度以及全球醫療保健基礎設施擴大的推動。
主要市場趨勢:皮下注射針市場趨勢包括採用安全設計的針頭以盡量減少針刺傷害、越來越傾向於使用較小規格的針頭以減少患者不適,以及出現無針注射系統以實現無痛藥物輸送。
地理趨勢:北美擁有發達的醫療保健體系、嚴格的安全法規以及最新針頭技術的高採用率,因此佔據了皮下注射針頭市場的最大佔有率。此外,慢性病數量和醫療支出的增加正推動該地區在全球醫藥市場中佔據領先地位。
競爭格局:皮下注射針產業的一些主要市場參與者包括 B. Braun Melsungen AG、Becton Dickinson and Company、Cardinal Health Inc.、Connecticut Hypodermics Inc.、EXELINT International Co.、Hi-Tech Syringes、McKesson Corporation、Medline Industries LP、Niprorum Corporation、Retractable Technologies Inc. (Smiths Medical. Medical.
挑戰與機會:皮下注射針市場面臨的挑戰包括對針頭處置和環境影響的日益關注、醫護人員的針刺傷害以及嚴格的監管要求。然而,在創新針頭技術的開發、新興市場的擴張以及旨在滿足未滿足需求和改善患者護理的研發合作方面仍存在著機會。
新的和先進的醫療程序以及醫療保健的日益普及增加了皮下注射針頭市場的需求。例如,美國疾病管制與預防中心 (CDC) 表示,美國每年約進行 160 億次注射,這表明針頭在現代醫學中的作用和重要性。除此之外,疫苗接種計劃、胰島素治療和其他醫療干預措施的增加也增加了對皮下注射針的需求,皮下注射針是這些醫療設備在拯救人們生命方面不可或缺的一部分,從而推動了市場的成長。除了全球人口老化之外,慢性疾病也增加了注射胰島素等藥物的需求,從而不斷增加注射器和針頭的需求。
糖尿病、癌症等全球慢性病的數量每天都在增加。根據世界衛生組織 (WHO) 的數據,非傳染性疾病是世界主要死亡原因,約佔所有死亡人數的 60%。因此,需要持續供應皮下注射針或靜脈注射針來注射胰島素和化療藥物等藥物。此外,隨著慢性病患者管理需求的不斷成長導致生產量不斷增加,皮下注射針市場正在經歷顯著成長。此外,生物技術的創新突破帶來了更多的注射藥物製造,從而增加了對皮下注射針頭的需求。
許多國家正在將預算分配給疾病預防和控制措施,例如大規模免疫接種和旨在預防愛滋病毒/愛滋病的措施。例如,聯合國永續發展目標針對所有年齡層的人改善健康和保健。作為這些措施的一部分,正在部署以皮下注射針為核心的疫苗接種計劃,以滿足對這些物品的需求。隨著各國政府越來越關注公共衛生議程並分配資源對抗傳染病,無針注射器市場將因改善醫療服務獲取途徑和結果的共同努力而經歷長期永續成長。例如,世界衛生組織(WHO)表示,2020年全球有1.16億嬰兒接種了三劑白喉-破傷風-百日咳(DTP)疫苗,展現了疫苗接種的巨大潛力。此外,美國的行動也為同樣的目標做出了貢獻。
安全注射針佔據大部分市場佔有率
安全皮下注射針可避免醫護人員和病患的針刺傷和感染危險。據美國職業安全與健康管理局 (OSHA) 稱,全球每年有數百萬醫護人員受到針刺傷。這是一個重大問題,主要是因為感染血液傳染疾病的風險很高。職業安全與健康管理局 (OSHA) 表示,實施可伸縮/屏蔽針頭等安全工程設備有助於擴大這些傷害之間的差距。例如,美國職業安全與健康管理局 (OSHA) 估計,在美國,每年使用安全工程設備可以預防約 3.85 億起針刺傷。隨著實施更安全工作環境的法規開始採用安全皮下注射針頭的使用,這種需求可能會增加,這將成為該產品後續市場佔有率的關鍵因素。
在藥物傳遞方面,慢性病的增加使得對藥物進行正確和準確管理的需求不斷增加,這直接導致了皮下注射針市場的需求。生物技術和製藥業的進步以及注射劑的發明也進一步提高了這項要求。由於全球大力推行傳染病接種,世界各地的疫苗接種計畫中針頭的使用量增加。新冠疫情凸顯了疫苗接種計畫在公共衛生中的重要性,從而增加了對皮下注射針頭的需求。此外,用於診斷目的的血液採集仍然是醫療機構中最重要的血液採集方法,確保了對皮下注射針頭的持續需求。這些應用確保了皮下注射針市場持續發展。
醫院和診所是主要的細分市場
醫院和診所推動了皮下注射針市場的成長,在提供醫療服務方面發揮關鍵作用。根據美國醫院協會 (AHA) 統計,截至 2021 年,美國至少有 6000 家獲得許可營運的醫院,多年來為數百萬患者提供服務。皮下注射針頭本身是不可或缺的醫療設備,用於醫院和診所進行的各種治療和程序,例如接種疫苗、注射、抽血和診斷。由於人口老化和慢性病患者人數不斷增加,導致醫院和診所的注射針消耗量大幅增加。此外,政府衛生機構制定的嚴格的感染控制協議確保了醫療品質並防止了醫院和診所內疾病的傳播,從而保證了患者的安全和卓越的醫療效果。
北美引領市場,佔據最大的注射針市場佔有率
該報告還對所有主要區域市場進行了全面的分析,包括北美(美國和加拿大);亞太地區(中國、日本、印度、韓國、澳洲、印尼等);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);拉丁美洲(巴西、墨西哥等);以及中東和非洲。根據報告,北美是最大的皮下注射針區域市場。
北美仍然是皮下注射針市場的主力,因為該地區擁有良好的醫療保健基礎設施,醫療保健支出在全國名列前茅,對皮下注射針等醫療設備的需求顯著增加。例如,美國醫療保險和醫療補助服務中心(CMS)報告稱,2020年美國醫療保健支出達到4.1兆美元,這意味著美國在醫療服務和產品上投入了大量資金。此外,美國食品藥物管理局 (FDA) 等機構實施了嚴格的監管標準,以確保對醫療保健提供者和患者至關重要的皮下注射針的有效性、可靠性和可用性。此外,該地區專注於創新且採用最新醫療保健實踐的醫療設備,從而促進了皮下注射針的使用,從而使北美成為全球皮下注射針市場的領導者。
市場研究報告也對市場競爭格局進行了全面的分析。也提供了所有主要公司的詳細資料。皮下注射針產業的主要市場參與者包括 B. Braun Melsungen AG、Becton Dickinson and Company、Cardinal Health Inc.、Connecticut Hypodermics Inc.、EXELINT International Co.、Hi-Tech Syringes、McKesson Corporation、Medline Industries LP、Nipro Corporation、Retractable Technologies Inc.、Smiths. Inc. Inc.、M.
The global hypodermic needles market size reached USD 3.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.91% during 2025-2033. The market is experiencing significant growth driven by increasing incidence of chronic diseases, rising demand for vaccinations and injectable medicines, needle breakthrough technologies that enhance comfort and safety for patients, and the expansion strategic healthcare infrastructure all over the world especially in the emerging economies.
Major Market Drivers: The hypodermic needles market growth is significantly driven by the rising prevalence of chronic diseases requiring injectable medications, increasing demand for vaccines and therapeutic drugs, technological advancements enhancing needle safety and patient comfort, and expanding healthcare infrastructure globally.
Key Market Trends: The hypodermic needles market trends include the adoption of safety-engineered needles to minimize needlestick injuries, the growing preference for smaller gauge needles for reduced patient discomfort, and the emergence of needle-free injection systems for painless drug delivery.
Geographical Trends: North America has the largest share of the hypodermic needles market due to its a developed healthcare system, stringent safety regulations and a high adoption rate of the latest needle technologies. Moreover, the increasing numbers of chronic diseases and healthcare expenditure are driving the region to take the lead in the global pharmaceutical market.
Competitive Landscape: Some of the major market players in the hypodermic needles industry include B. Braun Melsungen AG, Becton Dickinson and Company, Cardinal Health Inc., Connecticut Hypodermics Inc., EXELINT International Co., Hi-Tech Syringes, McKesson Corporation, Medline Industries LP, Nipro Corporation, Retractable Technologies Inc., Smiths Medical Inc. (ICU Medical Inc.), Terumo Corporation, among many others.
Challenges and Opportunities: The hypodermic needles market faces challenges sich as rising concerns regarding needle disposal and environmental impact, needlestick injuries among healthcare workers, and stringent regulatory requirements. However, opportunities exist in the development of innovative needle technologies, expansion into emerging markets, and collaborations for research and development aimed at addressing unmet needs and improving patient care.
New and advanced medical procedures and the rising spread of health care has augmented the hypodermic needles market demand. For instance, the Centers for Disease Control and Prevention (CDC) stated that there are approximately 16 billion injections performed yearly in the United States indicating the role and importance of needles in modern medicine. Apart from this, the increase of vaccination programs, insulin therapy and other medical interventions has escalated the demand for hypodermic needles which show an integral part of these medical equipment in saving people's life, thus propelling the market growth. In addition to aging populations worldwide, chronic diseases have heightened the need of injecting medications such as insulin which constantly increase demand of syringes and needles.
The number of chronic diseases from all over the world like diabetes and cancer is expanding every day. As per the World Health Organization (WHO), non-communicable diseases are the leading the cause of death in the world and these diseases are responsible for about 60% of all deaths. As a result, a constant supply of hypodermic or intravenous needles is required for injecting medications such as insulin and chemo drugs. Furthermore, with the increasing amount of production due to a growing need for chronically ill patient management, the hypodermic needles market is experiencing significant growth. Furthermore, the innovative breakthroughs in biotechnology result in more injectable medication manufacturing, escalating the demand for hypodermic needles escalates.
Many countries are allocating their budgets to disease prevention and control measures, such as mass immunization and measures aimed at preventing HIV/AIDS. For instance, the UNSDGs that targets all ages to improve health and wellness. As part of these initiatives, vaccination programs with hypodermic needles as the central element are being deployed, meeting the need for these items. With governments increasingly focusing on the public health agenda and allocating resources to combat infectious diseases, the needle-free injector market is set to experience a long-term sustainable growth due to such concerted efforts at improving the access to and the outcome of care. For instance, during the year of 2020, the World Health Organization (WHO) indicated that 116 million infants across the globe received three doses of the diphtheria-tetanus-pertussis (DTP) vaccine demonstrating the significant potential of vaccination. Additionally, actions as the USA have contributed to the same cause.
Safety hypodermic needles accounts for the majority of the market share
Safety hypodermic needles can avoid needlestick injury and infection hazards among healthcare staff and patients. As stated by the Occupational Safety and Health Administration (OSHA), millions of healthcare workers around the world are affected by needlestick injuries every year. It is a significant issue mainly because of high-risk of contracting bloodborne diseases. The Occupational Safety and Health Administration (OSHA) indicated that implementing safety-engineered devices like retractable/shielded needles can help to widen the gap between these injuries. For instance, OSHA estimates that about 385 million needlestick injuries can be maybe prevented in the United States every year using safety engineered devices. While regulations enforcing safer working environment are adopting the use of safety hypodermic needles, this is likely going to increase, which will be a key factor in the subsequent market share for that product.
In drug delivery, the rise of chronic diseases has escalated the need to have proper and accurate administration of medication which is directly contributing to hypodermic needles market demand. The progress of biotechnology and pharmaceuticals, and the invention of injectable types add to this high level of requests. There has been a rise in needle usage with vaccine programs worldwide mostly, due to the global push for inoculation against infectious diseases. The COVID-19 pandemic has heightened the significance of vaccination projects in public health prompting an increase of demand for hypodermic needles. Furthermore, blood sampling for diagnostic purposes is still the most important blood collection method in health facilities ensuring the consistent demand for hypodermic needles. These applications ensure the continued development of the hypodermic needles market.
Hospitals and clinics represent the leading market segment
Hospitals and clinics propel the hypodermic needles market growth, having a key role in provision of health services. According to the American Hospital Association (AHA), the country had at least 6000 licensed hospitals operating in 2021, serving millions of patients over the years. Hypodermic needles in their turn are indispensable medical equipment that is used throughout numerous treatments and procedures carried out in hospitals and clinics, such as vaccinations, injections, blood drawings and diagnostics. As a result of aging population and the growing number of people with chronic diseases, the consumption of hypodermic needles in hospitals and clinics leads to the fact that these establishments are gaining hypodermic needles in large amounts. In addition, stringent infection control protocols established by government health agencies ensure quality and prevent the spreading of diseases in hospitals and in the clinics, environment guaranteeing patient safety and excellent healthcare results.
North America leads the market, accounting for the largest hypodermic needles market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for hypodermic needles.
North America remains the force of the hypodermic needles market as the region features a good healthcare infrastructure and the healthcare expenditure among the highest in the country generates a notable demand for medical devices, such as hypodermic needles. For instance, the Centers for Medicare & Medicaid Services (CMS), reported that healthcare expenditure in the United States reached $4.1 trillion in 2020, meaning that the nation has invested vast amount of money in health services and products. Besides, agencies like the Food and Drug Administration (FDA) impose stringent regulatory standards that ensure the effectiveness, reliability, and usability of hypodermic needles which are essential for healthcare providers and patients. Also, the region concentrates on medical devices that are both innovative and uses the latest healthcare practices which in turn boosts the use of hypodermic needles, thus placing North America as a market leader in the global hypodermic needles market.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the hypodermic needles industry include B. Braun Melsungen AG, Becton Dickinson and Company, Cardinal Health Inc., Connecticut Hypodermics Inc., EXELINT International Co., Hi-Tech Syringes, McKesson Corporation, Medline Industries LP, Nipro Corporation, Retractable Technologies Inc., Smiths Medical Inc. (ICU Medical Inc.) and Terumo Corporation.